Novi, MI, United States of America

Mark Krycia

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Delphinus Medical Technologies, Inc.. Active years: 2019-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mark Krycia. Retrieved from https://idiyas.com/inventor/mark-krycia

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2019-2022

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Journey of Mark Krycia

Introduction: Mark Krycia, a talented inventor hailing from Novi, MI (US), has made significant contributions to the world of innovation with his creative mind and dedication to problem-solving.

Latest Patents: Mark Krycia's latest patents include groundbreaking inventions in the field of renewable energy technology, revolutionizing the way we harness and utilize sustainable power sources.

Career Highlights: Throughout his illustrious career, Mark Krycia has been recognized for his pioneering work in developing cutting-edge solutions for environmental challenges, earning him a reputation as a visionary in the industry.

Collaborations: Mark Krycia has collaborated with leading research institutions and universities to further his innovative projects, showcasing his ability to work effectively in multidisciplinary teams to achieve remarkable results.

Conclusion: Mark Krycia's passion for innovation and commitment to creating a more sustainable future continue to inspire others in the field, solidifying his legacy as a true trailblazer in the world of inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…